Loading clinical trials...

A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST) | Clinical Trials | Clareo Health

COMPLETED

A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)

A Real-world, Prospective, Observational Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)

NCT03505892•AbbVie

View on ClinicalTrials.gov

Summary

The objectives of this prospective observational study is to explore 1-year clinical response via both Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) after initiation of adalimumab therapy in AS patients from routine clinical practices in Taiwan.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Participants with confirmed AS.
•Participant will start adalimumab as treatment
•Participant must provide the written authorization form and agree to provide personal and/or health data prior to the entry into the study.

Exclusion Criteria

•Participant has been treated with any investigational drug or biologic within a minimum of 30 days or five half-lives (whichever is longer) of the drug prior to the Baseline Visit.
•Participants who fulfill any of the contraindications as per Humira label in Taiwan.

Locations (1)

Hualien Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation

Hualien City, Taiwan

Key Dates

Start Date

June 5, 2018

Primary Completion Date

October 25, 2021

Completion Date

October 25, 2021

Last Updated

July 20, 2023

Enrollment

ACTUAL participants

Conditions

Ankylosing Spondylitis (AS)

Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis

NCT06707194

Spondyloarthritis (SpA)Ankylosing Spondylitis (AS)

View study

RECRUITING

Bidirectional Cohort Study of Nanfang Spondyloarthritis

NCT06988813

Spondyloarthritis (SpA)Ankylosing Spondylitis (AS)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 20, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)

Inclusion Criteria

Exclusion Criteria

Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis

Bidirectional Cohort Study of Nanfang Spondyloarthritis

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service

Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).